shopping cart Your cart is empty
  • Home
  • Healthcare
  • Blood Testing Technology Market By Technology (Volume, Enzyme Linked Immunosarbent Assay (Elisa)), By Product And Service (Instr...

Blood Testing Technology Market By Technology (Volume, Enzyme Linked Immunosarbent Assay (Elisa)), By Product And Service (Instruments, Reagents), By End User (Blood Bank, Hospitals), Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Apr 25, 2016

Key Findings


The blood testing technologymarket is expected to grow at the CAGR of 10.5% during 2015-2022. The major factors driving the market are increasing patient population, growing healthcare centers and technological advancements. The patient population is increasing gradually due to growing infectious diseases such as viral, cancer, HIV, genetic disorder, thyroid which enhance the need for blood testing resulting in expansion of blood testing technology market. Growing healthcare center is another factor affecting the market. Increasing trend of point of care center is facilitating the patient’s rapid diagnosis with quick results.Although there are many factors driving the market yet there are some challenges faced by the market such as high capital investment and regulatory controls.


Market Segment Insight


The market is majorly segmented on the basis of technology, product and services and end user. On the basis of technology it is further segmented by volume, Enzyme Linked Immunosarbent Assay (ELISA), Next generation sequencing (NGS), Western blot assay. ELISA has the largest market, It is used to measure antibodies in the blood. On the basis of product and services it is segmented by Instruments, Reagents and Software and Service. On the basis of end user it is categorized in blood banks and hospitals.


Regional Insigh


Based on geography the market is segmented into North America, Europe, APAC and Row. North America has the largest market share globally and is followed by Europe, Asia pacific and Row. North America dominates the market due to increasing infectious diseases combined with technological advancement and increasing point of care testing. Europe is the second largest market due to increasing healthcare system. Asia Pacific is the fastest growing market due to growing healthcare service combined with technological advancement used in the industry such as automated blood collection equipment.


Competitive Insights


Some of the major market players are Becton, Dickinson and Company, Thermo Fisher Scientific, Inc, Ortho Clinical Diagnostics Inc, Bio Rad Laboratories, Inc, Abbott Laboratories, Roche Diagnostics, Baxter International. Product portfolio expansion, Acquisition, Mergers, Agreements are the key strategies adopted by the companies. Recently Abbott laboratories merged with Chilean pharmaceutical company which doubled the company presence in Latin America.

CHAP 1. METHODOLOGY & SCOPE 12
1.1. RESEARCH METHODOLOGY 12
1.2. RESEARCH SCOPE & ASSUMPTIONS 12
1.3. LIST OF DATA SOURCES 12


CHAP 2. EXECUTIVE SUMMARY 13
2.1. GLOBAL BLOOD TESTING TECHNOLOGY MARKETSUMMARY & KEY BUYING CRITERIA 13
2.2. GLOBAL BLOOD TESTING TECHNOLOGY MARKETOUTLOOK 13
2.3. MARKET SEGMENTATION ANALYSIS 13
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
2.5. GLOBAL BLOOD TESTING TECHNOLOGY MARKETVALUE CHAIN ANALYSIS 13
2.6. VENDOR LANDSCAPE 13


CHAP 3. GLOBAL BLOOD TESTING TECHNOLOGY MARKET 14
3.1. MARKET DRIVER ANALYSIS 14
3.1.1. INCREASING BLOOD DONATIONS 14
3.1.2. TECHNOLOGICAL ADVANCEMENTS 14
3.1.3. GROWING INFECTIOUS DISEASES 14
3.1.4. INCREASING POINT OF CARE TESTINGS 14
3.2. MARKET RESTRAINT ANALYSIS 14
3.2.1. HUGE COST OF NAT TESTING 14
3.2.2. REGULATORY APPROVAL 14
3.3. KEY OPPORTUNITIES 14
3.3.1. RISING MARKET IN DEVELOPING COUNTRIES 14
3.3.2. MULTIPLEXING 14
3.4. CHALLENGES 14
3.4.1. LACK OF SKILLED WORKFORCE 14
3.4.2. HIGH CAPITAL INVESTMENTS 14


CHAP 4. INDUSTRY ANALYSIS 15
4.1. GLOBAL BLOOD TESTING TECHNOLOGY MARKET– PORTER’S FIVE FORCE MODEL 15
4.2. GLOBAL BLOOD TESTING TECHNOLOGY MARKET– PESTEL ANALYSIS 15
4.3. GLOBAL BLOOD TESTING TECHNOLOGY MARKET– GAP ANALYSIS 15


CHAP 5. GLOBL GENOME EDITING TECHNOLOGY MARKET BY TECHNOLOGY 2012-2022 ($ BILLION) 16
5.1. GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY VOLUME, 2012-2022 ($ BILLION) 16
5.2. GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY ENZYME LINKED IMMUNOSARBENT ASSAY (ELISA) , 2012-2022 ($ BILLION) 16
5.2.1. RAPID TEST CARD METHOD 16
5.2.2. 1ST GENERATION (ELISA) 16
5.2.3. 2ND GENERATION (ELISA) 16
5.2.4. 3RD GENERATION (ELISA) 16
5.2.5. 4TH GENERATION (ELISA) 16


CHAP 6. GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY PRODUCT AND SERVICE 2012-2022 ($ BILLION) 17
6.1. GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY INSTRUMENTS, 2012-2022 ($ BILLION) 17
6.1.1. RENTAL PURCHASE 17
6.1.2. OUTRIGHT PURCHASE 17
6.2. GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY REAGENTS, 2012-2022 ($ BILLION) 17
6.2.1. ELISA 17
6.2.1.1. IMMUNOSORBENT 17
6.2.1.2. CONTROLS 17
6.2.1.3. CONJUGATE (ANTIBODY CONJUGATE ENZYME) 17
6.2.1.4. SUBSTRATE (SUBSTRATE OF ENZYMES) 17
6.2.1.5. SAMPLE DILUTES AND WASH SOLUTION 17


CHAP 7. GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY END USER 2012-2022 ($ BILLION) 18
7.1. GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY BLOOD BANK , 2012-2022 ($ BILLION) 18
7.2. GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY HOSPITALS, 2012-2022 ($ BILLION) 18
CHAP 8. GLOBAL BLOOD TESTING TECHNOLOGY MARKET, REGIONAL OUTLOOK 2012-2022 ($ BILLION) 19
8.1. GLOBAL BLOOD TESTING TECHNOLOGY MARKETBY REGION 2012-2022 ($ BILLION) 19
8.2. NORTH AMERICA 19
8.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 19
8.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.2.3.1. U.S. 19
8.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.2.3.2. CANADA 19
8.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.3. EUROPE 19
8.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 19
8.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 19
8.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 19
8.3.3.1. GERMANY 19
8.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.3.3.2. UK 20
8.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.3.3.3. FRANCE 20
8.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.3.3.4. REST OF EUROPE 20
8.3.3.4.1. OTHERS MARKET ESTIMATES AND FORECAST2012-2022($BILLION) 20
8.3.3.4.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 20
8.4. ASIA PACIFIC 20
8.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 20
8.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ BILLION) 20
8.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 20
8.4.3.1. CHINA 20
8.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
8.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
8.4.3.2. INDIA 21
8.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
8.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21
8.4.3.3. JAPAN 21
8.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
8.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($BILLION) 21
8.4.3.4. OTHERS 21
8.4.3.4.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($BILLION) 21
8.4.3.4.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($BILLION) 21
8.5. REST OF THE WORLD 21
8.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 21
8.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ BILLION) 21


CHAP 9. COMPETITIVE LANDSCAPE 22
9.1. BECTON, DICKINSON AND COMPANY 23
9.1.1. COMPANY OVERVIEW 23
9.1.2. SCOT ANALYSIS 23
9.1.3. PRODUCT BENCHMARKING 23
9.1.4. STRATEGIC INITIATIVES 23
9.2. BECKMAN COULTER 23
9.2.1. COMPANY OVERVIEW 23
9.2.2. SCOT ANALYSIS 23
9.2.3. PRODUCT BENCHMARKING 23
9.2.4. STRATEGIC INITIATIVES 23
9.3. THERMO FISHER SCIENTIFIC, INC 23
9.3.1. COMPANY OVERVIEW 23
9.3.2. SCOT ANALYSIS 23
9.3.3. PRODUCT BENCHMARKING 23
9.3.4. STRATEGIC INITIATIVES 23
9.4. ORTHO CLINICAL DIAGNOSTICS INC 23
9.4.1. COMPANY OVERVIEW 23
9.4.2. SCOT ANALYSIS 23
9.4.3. PRODUCT BENCHMARKING 23
9.4.4. STRATEGIC INITIATIVES 23
9.5. SIEMENS HEALTHCARE 23
9.5.1. COMPANY OVERVIEW 23
9.5.2. SCOT ANALYSIS 23
9.5.3. PRODUCT BENCHMARKING 23
9.5.4. STRATEGIC INITIATIVES 23
9.6. BIO RAD LABORATORIES, INC 23
9.6.1. COMPANY OVERVIEW 23
9.6.2. SCOT ANALYSIS 23
9.6.3. PRODUCT BENCHMARKING 24
9.6.4. STRATEGIC INITIATIVES 24
9.7. BIOMERIEUX 24
9.7.1. COMPANY OVERVIEW 24
9.7.2. SCOT ANALYSIS 24
9.7.3. PRODUCT BENCHMARKING 24
9.7.4. STRATEGIC INITIATIVES 24
9.8. ABBOTT LABORATORIES 24
9.8.1. COMPANY OVERVIEW 24
9.8.2. SCOT ANALYSIS 24
9.8.3. PRODUCT BENCHMARKING 24
9.8.4. STRATEGIC INITIATIVES 24
9.9. GRIFOLS 24
9.9.1. COMPANY OVERVIEW 24
9.9.2. SCOT ANALYSIS 24
9.9.3. PRODUCT BENCHMARKING 24
9.9.4. STRATEGIC INITIATIVES 24
9.10. ROCHE DIAGNOSTICS 24
9.10.1. COMPANY OVERVIEW 24
9.10.2. SCOT ANALYSIS 24
9.10.3. PRODUCT BENCHMARKING 24
9.10.4. STRATEGIC INITIATIVES 24
9.11. BAXTER INTERNATIONAL 24
9.11.1. COMPANY OVERVIEW 24
9.11.2. SCOT ANALYSIS 24
9.11.3. PRODUCT BENCHMARKING 24
9.11.4. STRATEGIC INITIATIVES 24
9.12. NOVATIS DIAGNOSTICS 25
9.12.1. COMPANY OVERVIEW 25
9.12.2. SCOT ANALYSIS 25
9.12.3. PRODUCT BENCHMARKING 25
9.12.4. STRATEGIC INITIATIVES 25
9.13. TRINITY BIOTECH AND ALERE, INC 25
9.13.1. COMPANY OVERVIEW 25
9.13.2. SCOT ANALYSIS 25
9.13.3. PRODUCT BENCHMARKING 25
9.13.4. STRATEGIC INITIATIVES 25
9.14. MERIDIAN BIOSCIENCE , INC 25
9.14.1. COMPANY OVERVIEW 25
9.14.2. SCOT ANALYSIS 25
9.14.3. PRODUCT BENCHMARKING 25
9.14.4. STRATEGIC INITIATIVES 25
9.15. CEPHEID CORPORATION 25
9.15.1. COMPANY OVERVIEW 25
9.15.2. SCOT ANALYSIS 25
9.15.3. PRODUCT BENCHMARKING 25
9.15.4. STRATEGIC INITIATIVES 25

TABLE 1 GLOBL GENOME EDITING TECHNOLOGY MARKET GLOBL GENOME EDITING TECHNOLOGY MARKET BY TECHNOLOGY 2012-2022 ($ BILLION) 25
TABLE 2 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY VOLUME, 2012-2022 ($ BILLION) 25
TABLE 3 TRANSCRIPTION MEDIATED AMPLIFICATION 25
TABLE 4 REAL TIME POLYMERASE CHAIN REACTION (PCR) 26
TABLE 5 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY ENZYME LINKED IMMUNOSARBENT ASSAY (ELISA) , 2012-2022 ($ BILLION) 26
TABLE 6 RAPID TEST CARD METHOD 26
TABLE 7 1ST GENERATION (ELISA) 26
TABLE 8 2ND GENERATION (ELISA) 26
TABLE 9 3RD GENERATION (ELISA) 26
TABLE 10 4TH GENERATION (ELISA) 26
TABLE 11 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY NEXT GENERATION SEQUENCING(NGS), 2012-2022 ($ BILLION) 26
TABLE 12 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY WESTREN BLOT ASSAY, 2012-2022 ($ BILLION) 26
TABLE 13 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY PRODUCT AND SERVICE 2012-2022 ($ BILLION) 26
TABLE 14 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY INSTRUMENTS, 2012-2022 ($ BILLION) 26
TABLE 15 RENTAL PURCHASE 26
TABLE 16 OUTRIGHT PURCHASE 26
TABLE 17 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY REAGENTS, 2012-2022 ($ BILLION) 26
TABLE 18 ELISA 26
TABLE 19 IMMUNOSORBENT 26
TABLE 20 CONTROLS 26
TABLE 21 CONJUGATE (ANTIBODY CONJUGATE ENZYME) 26
TABLE 22 SUBSTRATE (SUBSTRATE OF ENZYMES) 26
TABLE 23 SAMPLE DILUTES AND WASH SOLUTION 26
TABLE 24 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY SOFTWARE AND SEVICE, 2012-2022 ($ BILLION) 26
TABLE 25 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY END USER 2012-2022 ($ BILLION) 26
TABLE 26 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY BLOOD BANK , 2012-2022 ($ BILLION) 26
TABLE 27 GLOBAL BLOOD TESTING TECHNOLOGY MARKET BY HOSPITALS, 2012-2022 ($ BILLION) 26
TABLE 28 NORTH AMERICA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 27
TABLE 29 NORTH AMERICA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 27
TABLE 30 NORTH AMERICA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27
TABLE 31 U.S. GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 27
TABLE 32 U.S. GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27
TABLE 33 CANADA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 27
TABLE 34 CANADA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 –2022 ($ BILLION) 27
TABLE 35 CANADA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27
TABLE 36 EUROPE GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 27
TABLE 37 EUROPE GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 27
TABLE 38 EUROPE GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27
TABLE 39 GERMANY GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 27
TABLE 40 GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 27
TABLE 41 UK GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 28
TABLE 42 UK GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 28
TABLE 43 ASIA PACIFIC GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 28
TABLE 44 ASIA PACIFIC GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY REGION, 2012 – 2022 ($ BILLION) 28
TABLE 45 ASIA PACIFIC GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 28
TABLE 46 CHINA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 28
TABLE 47 CHINA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 28
TABLE 48 INDIA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 28
TABLE 49 INDIA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 28
TABLE 50 JAPAN GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 28
TABLE 51 JAPAN GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 28
TABLE 52 MIDDLE EAST & AFRICA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 28
TABLE 53 MIDDLE EAST & AFRICA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 28
TABLE 54 CENTRAL & SOUTH AMERICA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST, 2012 – 2022 ($ BILLION) 29
TABLE 55 CENTRAL & SOUTH AMERICA GLOBAL BLOOD TESTING TECHNOLOGY MARKETMARKET ESTIMATES AND FORECAST BY APPLICATION, 2012 – 2022 ($ BILLION) 29

FIGURE 1 MARKET SHARE BY REGIONS 29
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 8 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 9 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 10 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 11 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29
FIGURE 13 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ BILLION) 29

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)